Butorphanol — Discount Pricing

Other medications in Pain & Inflammation

• Caffeine-Ergotamine
• Capsaicin
• Capsaicin Patch
• Carisoprodol
• Chlorzoxazone
• Codeine
• Dantrolene
• Diclofenac Gel

About Butorphanol

Butorphanol is a potent medication primarily used for moderate to severe pain relief, and sometimes for specific types of headaches like migraines. If you've been prescribed butorphanol, managing the cost can be a significant concern. TheDrugClub is dedicated to helping our members access essential medications affordably, offering substantial savings on prescriptions like butorphanol, making your healthcare more manageable.

Understanding Butorphanol: A Closer Look at Your Pain Relief

Butorphanol is a prescription medication primarily known for its role in managing moderate to severe pain. It's often prescribed for post-operative pain, pain associated with cancer, and in some cases, for the treatment of migraine headaches, particularly in its nasal spray form. It can also be used as a pre-operative medication or for pain relief during labor.

How Does Butorphanol Work?

Butorphanol belongs to a class of drugs known as opioid agonist-antagonists. This means it acts on specific opioid receptors in the brain and spinal cord, similar to traditional opioids, to reduce the sensation of pain. However, unlike full opioid agonists, butorphanol also has antagonist (blocking) effects at other opioid receptors. This unique mechanism allows it to provide effective pain relief while potentially having a different side effect profile compared to some other opioid medications. It's available in various forms, including injectable solutions and a nasal spray, allowing for different routes of administration depending on the condition being treated and the speed of relief required.

Typical Costs and TheDrugClub Savings

The cost of butorphanol can vary significantly based on factors such as the dosage, the form of the medication (e.g., injectable versus nasal spray), the pharmacy you use, and your insurance coverage. For individuals without insurance or with high deductibles, the out-of-pocket cost for butorphanol can be substantial. Prices can fluctuate widely, making it challenging to predict your exact expense.

This is where TheDrugClub steps in. As a prescription savings membership program, we work to make essential medications like butorphanol more accessible and affordable. While we cannot guarantee specific active-formulary coverage for every member's unique insurance plan—as this is determined by individual insurance providers—TheDrugClub focuses on providing substantial discounts off the retail price. Our members gain access to pre-negotiated rates that

The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.

What Butorphanol is approved for (FDA label)

Butorphanol tartrate nasal spray is indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. Limitations of Use : Because of the risks of addiction, abuse, misuse, overdose, and death, which can occur at any dosage or duration, and persist over the course of therapy [see WARNINGS ] , reserve opioid analgesics, including butorphanol tartrate, for use in patients for whom alternative treatment options are ineffective, not tolerated, or would be otherwise inadequate to provide sufficient management of pain.

Source: Read the full FDA label on DailyMed. Label effective date: September 9, 2026.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Boxed warning for Butorphanol (FDA label)

WARNING: SERIOUS AND LIFE-THREATENING RISKS FROM USE OF BUTORPHANOL TARTRATE NASAL SPRAY Addiction, Abuse, and Misuse Because the use of butorphanol tartrate nasal spray exposes patients and other users to the risks of opioid addiction, abuse, and misuse, which can lead to overdose and death, assess each patient’s risk prior to prescribing and reassess all patients regularly for the development of these behaviors and conditions [see WARNINGS ]. Life-Threatening Respiratory Depression Serious, life-threatening, or fatal respiratory depression may occur with use of butorphanol tartrate nasal spray, especially during initiation or following a dosage increase. To reduce the risk of respiratory depression, proper dosing and titration of butorphanol tartrate nasal spray are essential [see WARNINGS ]. Accidental Exposure Accidental exposure of even one dose of butorphanol tartrate nasal spray, especially in children, can result in a fatal overdose of butorphanol tartrate [see WARNINGS ]. Risks From Concomitant Use With Benzodiazepines Or Other CNS Depressants Concomitant use of opioids with benzodiazepines or other central nervous system (CNS) depressants, including alcohol, may result in profound sedation, respiratory depression, coma, and death.

Source: FDA prescribing information (DailyMed). Set ID: b8e48063-0b40-ee43-85c1-4ef2de80c404. SPL document ID: ff8775a3-e234-577e-5492-beb7a49e3f22. Label effective date: September 9, 2026. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Adverse reactions for Butorphanol (FDA label)

Clinical Trial Experience A total of 788 patients were studied in premarketing clinical trials of butorphanol tartrate nasal spray. In nearly all cases the type and incidence of side effects with butorphanol were those commonly observed with opioid analgesics. The adverse experiences described below are based on data from short-term and long-term clinical trials in patients receiving intranasal butorphanol, except acute studies in normal subjects. There has been no attempt to correct for placebo effect or to subtract the frequencies reported by placebo-treated patients in controlled trials. The most frequently reported adverse experiences across all clinical trials with Butorphanol Tartrate Nasal Spray were somnolence (49%), dizziness (23%), nausea and/or vomiting (8%).

Source: FDA prescribing information (DailyMed). Set ID: b8e48063-0b40-ee43-85c1-4ef2de80c404. SPL document ID: ff8775a3-e234-577e-5492-beb7a49e3f22. Label effective date: September 9, 2026. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Contraindications for Butorphanol (FDA label)

Butorphanol tartrate nasal spray is contraindicated in: Patients with significant respiratory depression [see WARNINGS ] Patients with acute or severe bronchial asthma in an unmonitored setting or in the absence of resuscitative equipment [see WARNINGS ] Patients with known or suspected gastrointestinal obstruction, including paralytic ileus [see WARNINGS ] Patients with hypersensitivity to butorphanol tartrate, the preservative benzethonium chloride, or any of the formulation excipients (e.g., anaphylaxis) [see WARNINGS ])

Source: FDA prescribing information (DailyMed). Set ID: b8e48063-0b40-ee43-85c1-4ef2de80c404. SPL document ID: ff8775a3-e234-577e-5492-beb7a49e3f22. Label effective date: September 9, 2026. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.